User profiles for M. NAGY-VINCZE
Melinda Nagy-VinczeDebreceni Egyetem, Klinikai Immunológia Tanszék Verified email at med.unideb.hu Cited by 1177 |
[HTML][HTML] Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy …
…, K Danko, M Nagy-Vincze, L Bodoki, M Dastmalchi… - Journal of …, 2019 - Elsevier
Objectives To determine prevalence and co-existence of myositis specific autoantibodies (MSAs)
and myositis associated autoantibodies (MAAs) and associated clinical characteristics …
and myositis associated autoantibodies (MAAs) and associated clinical characteristics …
Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory …
Idiopathic inflammatory myopathies (IIMs) are chronic systemic autoimmune diseases
characterised by symmetrical, proximal muscle weakness. Dermatomyositis represents one subset …
characterised by symmetrical, proximal muscle weakness. Dermatomyositis represents one subset …
COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
…, J Campagne, A Meyer, M Nagy‐Vincze… - Muscle & …, 2022 - Wiley Online Library
Introduction/Aims In this study we investigated COVID‐19 vaccination–related adverse
events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) …
events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) …
[HTML][HTML] Retrospective analysis of cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort
Association between cancer and myositis has been extensively reported and malignancy is
a potentially life-threating complication in myositis. In this retrospective study authors give an …
a potentially life-threating complication in myositis. In this retrospective study authors give an …
[HTML][HTML] Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis
MicroRNA (miRNA) research has intensively developed over the past decade. Characterization
of dysregulated miRNA expression profiles could give a better understanding of the …
of dysregulated miRNA expression profiles could give a better understanding of the …
[HTML][HTML] Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases
S Mogyoróssy, M Nagy-Vincze, Z Griger, K Dankó… - Autoimmunity …, 2023 - Elsevier
Myalgia, myopathy and myositis are the most important types of muscle impairment in
immune-mediated inflammatory arthropathies and connective tissue diseases. Multiple …
immune-mediated inflammatory arthropathies and connective tissue diseases. Multiple …
Pregnancy outcome in idiopathic inflammatory myopathy patients in a multicenter study
M Nagy-Vincze, J Vencovsky, IE Lundberg… - The Journal of …, 2014 - jrheum.org
Pregnancy in autoimmune diseases may be complicated for both the fetus and the mother.
Polymyositis (PM) and dermatomyositis (DM) are autoimmune diseases that affect women …
Polymyositis (PM) and dermatomyositis (DM) are autoimmune diseases that affect women …
Pharmacological management of dermatomyositis
Z Griger, M Nagy-Vincze, K Dankó - Expert Review of Clinical …, 2017 - Taylor & Francis
Introduction: Dermatomyositis is a rare heterogeneous systemic autoimmune disease with
multiple organ involvement which can result in significant disability and mortality. Despite the …
multiple organ involvement which can result in significant disability and mortality. Despite the …
Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis
…, S Szilágyi, R Faludi, M Nagy-Vincze… - The Journal of …, 2015 - jrheum.org
Objective. To identify early echocardiographic abnormalities at the time of diagnosis of
polymyositis (PM) and dermatomyositis (DM) and follow the echocardiographic findings during …
polymyositis (PM) and dermatomyositis (DM) and follow the echocardiographic findings during …
Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment
Á Diószegi, T Tarr, M Nagy-Vincze, M Nánásy-Vass… - Lupus, 2018 - journals.sagepub.com
Antiphospholipid syndrome is characterized by multiple arterial and/or venous thrombotic
events, recurrent fetal losses in the presence of antiphospholipid antibodies (aPL). …
events, recurrent fetal losses in the presence of antiphospholipid antibodies (aPL). …